Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, ... In 2023, the company reported $6.7 billion in profit on $28.2 billion in sales.
Volume growth of Amgen's (AMGN) key drugs like Prolia, Kyprolis, Repatha and others and biosimilars portfolio is expected to have been partially offset by biosimilar/generic competition for mature ...
The company was reportedly the center of a bidding war between Amgen, Johnson & Johnson and Sanofi. [18] In May 2023, the Federal Trade Commission said it would sue to block the deal in an attempt to control drug prices. [17] [19] [20] The acquisition was completed in October 2023 after mutually resolving the litigation. [5]
Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
An Amgen sign is seen at the company's office in South San Francisco, Calif., in this Oct. 21, 2013, file photo. ... Lilly recorded a total of $2 billion from its GLP-1 products in 2023, while ...